Related Experiment Video

Updated: Sep 20, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1

Veronique Gagnon1, Marie-Eve St-Germain, Sophie Parent

  • 1Department of Chemistry and Biology, Medical Biology Section, University of Quebec at Trois-Rivieres, C.P. 500, Trois-Rivieres, Quebec G9A 5H7, Canada.

International Journal of Oncology
|July 31, 2003
PubMed

Insights

Mutations in phosphatase tensin homologue (PTEN) in endometrial cancer activate the PI 3-K/Akt pathway, promoting cell survival. Inhibiting this pathway increases apoptosis and reduces cIAP-1, a key survival protein.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Mutations in the tumor suppressor phosphatase tensin homologue (PTEN) are common in endometrial cancers.
  • PTEN normally inhibits the PI 3-K/Akt pathway, which is crucial for cell survival.
  • Dysregulation of this pathway contributes to cancer progression.

Purpose of the Study:

  • To investigate the role of the PI 3-K/PTEN/Akt pathway in endometrial cancer cell survival.
  • To determine how PTEN mutations affect Akt activation and downstream survival factors.
  • To explore the therapeutic potential of targeting this pathway.

Main Methods:

  • Utilized endometrial cancer cell lines with wild-type PTEN (HEC-1-A) and mutated PTEN (RL-95-2, Ishikawa).
  • Assessed Akt1/2 mRNA and protein phosphorylation levels.
  • Measured expression of survival factors Bcl-2, XIAP, cIAP-1, and cIAP-2.
  • Administered PI 3-K inhibitor (Wortmannin) and used Akt overexpression vectors.

Main Results:

  • Mutated PTEN cells showed high Akt1/2 mRNA and phospho-Akt levels.
  • cIAP-1 protein expression correlated with phospho-Akt levels.
  • Wortmannin treatment decreased Akt phosphorylation and increased apoptosis in mutated PTEN cells, down-regulating cIAP-1.
  • Wortmannin had no effect on wild-type PTEN cells.
  • Bcl-2 expression was not regulated by Akt.
  • Akt overexpression up-regulated cIAP-1 expression.

Conclusions:

  • Akt plays a critical role in endometrial cancer cell survival.
  • This survival is mediated through the up-regulation of cIAP-1, an inhibitor of apoptosis protein.
  • Targeting the PI 3-K/Akt pathway, particularly in PTEN-mutated cancers, may be a viable therapeutic strategy.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.